Samsung Biologics Acquires GSK U.S. Manufacturing Site
INCHEON, South Korea & ROCKVILLE, Maryland, USA — March 31, 2026 Samsung Biologics has officially completed the acquisition of...
Mergers & Acquisitions for New Therapy
Recordati Confirms CVC Interest in Major Pharma M&A Deal
MILAN, Italy, March 26, 2026 Recordati S.p.A. has confirmed receiving a non-binding indication of interest from CVC Capital Partners...
Lilly to Acquire Centessa in $7.8B Pharma Deal
INDIANAPOLIS, USA & BOSTON, USA & LONDON, UK, March 31, 2026 Eli Lilly and Company has announced a definitive...
Novartis Acquires Excellergy in $2B Allergy Innovation Deal
Basel, Switzerland | March 27, 2026 Strategic Acquisition Strengthens Allergy Leadership Novartis has announced a major strategic move to...
Merck to Acquire Terns to Strengthen CML Pipeline
RAHWAY, New Jersey & FOSTER CITY, California, March 25, 2026 Merck & Co. has announced a definitive agreement to...
Quotient Therapeutics, Merck Sign $2.2B IBD Deal
CAMBRIDGE, MASSACHUSETTS, March 24, 2026 Quotient Therapeutics has announced a multi-year research collaboration with Merck & Co. to discover...
Gilead to Acquire Ouro for $2.1B Autoimmune Pipeline Boost
FOSTER CITY, CALIFORNIA, March 24, 2026 Gilead Sciences has announced a definitive agreement to acquire Ouro Medicines in a...
Embecta Acquires Owen Mumford to Expand Drug Delivery
Parsippany, New Jersey, USA | March 19, 2026 Embecta Corp. has announced a definitive agreement to acquire Owen Mumford...
Novartis $3B Oncology Deal with Synnovation to Boost Breast Cancer Pipeline
BASEL, Switzerland, March 20, 2026 Novartis announced a major strategic acquisition to strengthen its oncology portfolio, agreeing to acquire...
Voro Therapeutics Partners with Daiichi Sankyo on ADCs
SAN DIEGO, CA, March 17, 2026 Voro Therapeutics has announced a research collaboration with Daiichi Sankyo to advance its...